Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|January 26, 2021
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumoursSunit Sarkar, Ben Tran, Lisa Horvath, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumorsAnna C Pavlick, Jennifer Wu, John Roberts, et al.
British Journal of Cancer|January 19, 2019
Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancerChee Khoon Lee, Clare Scott, Geoffrey J Lindeman, et al.
Plos One|January 6, 2011
A phase II trial of sorafenib in metastatic melanoma with tissue correlatesPatrick A Ott, Anne Hamilton, Christina Min, et al.
Seminars in Oncology|October 3, 2003
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working GroupJames H Doroshow, Timothy W Synold, David Gandara, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|May 3, 2016
Stimulation of Critically Ill Patients: Relationship to SedationMary Jo Grap, Cindy L Munro, Paul A Wetzel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 8, 2012
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432Patricia M LoRusso, Karthik Venkatakrishnan, Ramesh K Ramanathan, et al.
Seminars in Oncology|October 3, 2003
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working groupChris H Takimoto, Scot C Remick, Sunil Sharma, et al.
BMJ Open|April 2, 2022
FAST-IT: Find A Simple Test - In TIA (transient ischaemic attack): a prospective cohort study to develop a multivariable prediction model for diagnosis of TIA through proteomic discovery and candidate lipid mass spectrometry, neuroimaging and machine learning-study protocolAustin G Milton, Stephan Lau, Karlea L Kremer, et al.
Asia-Pacific Journal of Clinical Oncology|November 4, 2025
Real-World Trends and Outcomes for Localized High-Grade Soft Tissue Sarcoma: Insights from a Sarcoma Unit in AustraliaAdel Shahnam, Jeremy Lewin, Anne Hamilton, et al.
Pageof 8